Alexander Glaros
Pediatric Hematology-Oncology · Detroit, MINPI 1114330339
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Agios Pharmaceuticals, Inc. accounts for 69.9% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $28,895, more than ten times the $206 reported in 2019.
Across 87 payments — averaging $729.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Agios Pharmaceuticals, Inc.$44K
- Pfizer$9K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$4K
- Global Blood Therapeutics, Inc.$3K
- Genetix Biotherapeutics Inc$1K
- Novartis$120
- plus $517 from 8 others
Across 69 payments — averaging $5365.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Agios Pharmaceuticals, Inc.$221K
- Global Blood Therapeutics, Inc.$75K
- Bausch Health US, LLC$70K
- Novartis$2K
- Pfizer$2K
What the payments were for
- Consulting fees$37,07058%
- Speaking & faculty fees$14,48823%
- Travel & lodging$8,26613%
- Food & beverage$3,6776%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Agios Pharmaceuticals, Inc. | 49 | $44,397 |
| Pfizer | 13 | $9,467 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $4,412 |
| Global Blood Therapeutics, Inc. | 4 | $3,348 |
| Genetix Biotherapeutics Inc | 2 | $1,240 |
| Novartis | 2 | $120 |
| Chiesi USA, Inc. | 1 | $119 |
| Emmaus Medical, Inc. | 6 | $117 |
| Silvergate Pharmaceuticals, Inc. | 1 | $107 |
| Vertex | 2 | $67 |
| Medunik USA Inc. | 1 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| AstraZeneca | 1 | $17 |
| RARE Disease Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$63,501 in reported general payments places this provider in the 85th percentile of 84 pediatric hematology-oncology providers in Michigan.
See all pediatric hematology-oncology providers in Michigan →
Other pediatric hematology-oncology in Detroit
- Michael CallaghanDetroit$374K
- Ahmar ZaidiDetroit$119K
- Katherine ReglingDetroit$81K
- Brian BermanDetroit$28K
- Roland ChuDetroit$12K
- Alissa MartinDetroit$6K
- Edward PeresDetroit$5K
- Mark ShamounDetroit$3K
- Meret HenryDetroit$3K
- Gianna ValentiDetroit$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.